Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 314

  • Showing results for haglund c. Search instead for Hglund C (1 item)
1.

Prevalence of high-risk human papillomavirus infection and cancer gene mutations in nonmalignant tonsils.

Ilmarinen T, Munne P, Hagström J, Haglund C, Auvinen E, Virtanen EI, Haesevoets A, Speel EJM, Aaltonen LM.

Oral Oncol. 2017 Oct;73:77-82. doi: 10.1016/j.oraloncology.2017.08.010. Epub 2017 Aug 18.

PMID:
28939080
2.

N-glycomic profiling of pheochromocytomas and paragangliomas separates metastatic and non-metastatic disease.

Leijon H, Kaprio T, Heiskanen A, Satomaa T, Hiltunen JO, Miettinen MM, Arola J, Haglund C.

J Clin Endocrinol Metab. 2017 Aug 17. doi: 10.1210/jc.2017-00401. [Epub ahead of print]

PMID:
28938401
3.

Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients.

Jouhi L, Mohamed H, Mäkitie A, Remes SM, Haglund C, Atula T, Hagström J.

Cancer Immunol Immunother. 2017 Aug 30. doi: 10.1007/s00262-017-2054-3. [Epub ahead of print]

PMID:
28856441
4.

High PROX1 expression in gastric cancer predicts better survival.

Laitinen A, Böckelman C, Hagström J, Kokkola A, Kallio P, Haglund C.

PLoS One. 2017 Aug 30;12(8):e0183868. doi: 10.1371/journal.pone.0183868. eCollection 2017.

5.

Immunohistochemical analysis reveals variations in proteasome tissue expression in C. elegans.

Mikkonen E, Haglund C, Holmberg CI.

PLoS One. 2017 Aug 17;12(8):e0183403. doi: 10.1371/journal.pone.0183403. eCollection 2017.

6.

C-myc expression in adrenocortical tumours.

Pennanen M, Hagström J, Heiskanen I, Sane T, Mustonen H, Arola J, Haglund C.

J Clin Pathol. 2017 Aug 11. pii: jclinpath-2017-204503. doi: 10.1136/jclinpath-2017-204503. [Epub ahead of print]

PMID:
28801349
7.

Evaluation of the budding and depth of invasion (BD) model in oral tongue cancer biopsies.

Almangush A, Leivo I, Siponen M, Sundquist E, Mroueh R, Mäkitie AA, Soini Y, Haglund C, Nieminen P, Salo T.

Virchows Arch. 2017 Aug 2. doi: 10.1007/s00428-017-2212-1. [Epub ahead of print]

PMID:
28766010
8.

UCHL5 expression associates with improved survival in lymph-node-positive rectal cancer.

Arpalahti L, Hagström J, Mustonen H, Lundin M, Haglund C, Holmberg CI.

Tumour Biol. 2017 Jul;39(7):1010428317716078. doi: 10.1177/1010428317716078.

PMID:
28681694
9.

Nuclear ubiquitin C-terminal hydrolase L5 expression associates with increased patient survival in pancreatic ductal adenocarcinoma.

Arpalahti L, Saukkonen K, Hagström J, Mustonen H, Seppänen H, Haglund C, Holmberg CI.

Tumour Biol. 2017 Jun;39(6):1010428317710411. doi: 10.1177/1010428317710411.

PMID:
28653876
10.

Early stage minor salivary gland adenoid cystic carcinoma has favourable prognosis.

Hämetoja H, Hirvonen K, Hagström J, Leivo I, Saarilahti K, Apajalahti S, Haglund C, Mäkitie A, Bäck L.

Virchows Arch. 2017 Jun 10. doi: 10.1007/s00428-017-2163-6. [Epub ahead of print]

PMID:
28600602
11.

Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis.

Saraswat M, Joenväärä S, Seppänen H, Mustonen H, Haglund C, Renkonen R.

Cancer Med. 2017 Jul;6(7):1738-1751. doi: 10.1002/cam4.1107. Epub 2017 Jun 1.

12.

Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.

Jiang Y, Marinescu VD, Xie Y, Jarvius M, Maturi NP, Haglund C, Olofsson S, Lindberg N, Olofsson T, Leijonmarck C, Hesselager G, Alafuzoff I, Fryknäs M, Larsson R, Nelander S, Uhrbom L.

Cell Rep. 2017 May 2;19(5):1080-1081. doi: 10.1016/j.celrep.2017.04.053. No abstract available.

13.

Changing trends in the management of the neck in oropharyngeal squamous cell carcinoma.

Jouhi L, Atula T, Saarilahti K, Hagström J, Haglund C, Mohamed H, Mäkitie A, Keski-Säntti H.

Head Neck. 2017 Jul;39(7):1412-1420. doi: 10.1002/hed.24781. Epub 2017 May 2.

PMID:
28464452
14.

A nationwide study on parathyroid carcinoma.

Ryhänen EM, Leijon H, Metso S, Eloranta E, Korsoff P, Ahtiainen P, Kekäläinen P, Tamminen M, Ristamäki R, Knutar O, Löyttyniemi E, Niskanen L, Väisänen M, Heiskanen I, Välimäki MJ, Laakso M, Haglund C, Arola J, Schalin-Jäntti C.

Acta Oncol. 2017 Jul;56(7):991-1003. doi: 10.1080/0284186X.2017.1306103. Epub 2017 Mar 31.

PMID:
28362521
15.

Positive staining for cellulose in oral pulse granuloma.

Virkkunen S, Wolff H, Haglund C, Højgaard C, Winther JR, Willemoës M, Vogel U, Hagström J.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Apr;123(4):464-467. doi: 10.1016/j.oooo.2016.11.022. Epub 2016 Dec 9.

PMID:
28189527
16.

Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.

Jiang Y, Marinescu VD, Xie Y, Jarvius M, Maturi NP, Haglund C, Olofsson S, Lindberg N, Olofsson T, Leijonmarck C, Hesselager G, Alafuzoff I, Fryknäs M, Larsson R, Nelander S, Uhrbom L.

Cell Rep. 2017 Jan 24;18(4):977-990. doi: 10.1016/j.celrep.2017.01.003.

17.

In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia.

Strese S, Hassan SB, Velander E, Haglund C, Höglund M, Larsson R, Gullbo J.

Oncotarget. 2017 Jan 24;8(4):6341-6352. doi: 10.18632/oncotarget.13856.

18.

Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition.

Segerman A, Niklasson M, Haglund C, Bergström T, Jarvius M, Xie Y, Westermark A, Sönmez D, Hermansson A, Kastemar M, Naimaie-Ali Z, Nyberg F, Berglund M, Sundström M, Hesselager G, Uhrbom L, Gustafsson M, Larsson R, Fryknäs M, Segerman B, Westermark B.

Cell Rep. 2016 Dec 13;17(11):2994-3009. doi: 10.1016/j.celrep.2016.11.056.

19.

Systemic matrix metalloproteinase-8 response in chronic tonsillitis.

Ilmarinen T, Lont T, Hagström J, Tervahartiala T, Sorsa T, Haglund C, Munck-Wickland E, Ramqvist T, Dalianis T, Aaltonen LM.

Infect Dis (Lond). 2017 Apr;49(4):302-307. doi: 10.1080/23744235.2016.1248484. Epub 2016 Nov 2.

PMID:
27804311
20.

The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.

Køstner AH, Kersten C, Löwenmark T, Ydsten KA, Peltonen R, Isoniemi H, Haglund C, Gunnarsson U, Isaksson B.

J Surg Oncol. 2016 Dec;114(7):895-899. doi: 10.1002/jso.24415. Epub 2016 Oct 3.

PMID:
27696432

Supplemental Content

Loading ...
Support Center